Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Elan buyback priced at $11.25 reduces Royalty bid
Reuters
Thursday, April 18, 2013 - 10:39am
tags:
Royalty Pharma, Elan, stock buyback
Pfizer CEO Was Highest Paid Among Pharma Companies Last Year
Bloomberg
Thursday, April 18, 2013 - 10:37am
tags:
Pfizer, executive pay, Ian Read
Baxter posts lower earnings on acquisition-related expenses
Reuters
Thursday, April 18, 2013 - 8:37am
tags:
earnings, Baxter International
Cipla steamrolls into Enbrel market with biosimilar of Amgen drug
Fierce Pharma
Thursday, April 18, 2013 - 8:34am
tags:
Cipla, Enbrel, Amgen, biosimilars, India, anemia
Merck & Co. Picks Up Exclusive Option on Xenon CV Drugs
Genetic Engineering News
Thursday, April 18, 2013 - 8:22am
tags:
Merck, Xenon
GSK’s Contract Manufacturing Delays Cause Shortage of Restless Leg Treatment
Outsourcing Pharma
Thursday, April 18, 2013 - 8:21am
tags:
restless legs syndrome, GSK, CMOs, drug shortages, XenoPort, Astellas, Horizant
GTx And Trius Therapeutics: 2 Top Biotech Buys For 2013
Seeking Alpha
Thursday, April 18, 2013 - 8:05am
tags:
GTx, Trius Therapeutics, enobosarm, TR-701
Exact Sciences cancer test meets goal, but disappoints investors
Reuters
Thursday, April 18, 2013 - 8:03am
tags:
EXACT Sciences, colorectal cancer
Can Pfizer Keep Up The Positive Momentum?
Seeking Alpha
Thursday, April 18, 2013 - 8:01am
tags:
Pfizer
Declines From Sanofi Drive Down Drug Industry
TheStreet.com
Thursday, April 18, 2013 - 8:00am
tags:
Sanofi
How Big Will Johnson & Johnson’s Legal Bill Grow?
Wall St. Cheat Sheet
Thursday, April 18, 2013 - 7:58am
tags:
JNJ
Clean Superiority Sweep For Dulaglutide Could Reshape Diabetes Market
Seeking Alpha
Wednesday, April 17, 2013 - 4:40pm
tags:
diabetes, Eli Lilly, dulaglutide, Novo Nordisk, Sanofi
3 Things You Need to Watch at Johnson & Johnson
Motley Fool
Wednesday, April 17, 2013 - 4:38pm
tags:
JNJ, devices, Invokana, Stelara
3 Potential Game Changers for America's No. 1 Killer
Motley Fool
Wednesday, April 17, 2013 - 4:36pm
tags:
heart disease, Novartis, serelaxin, Pfizer, Inspra, Regeneron, Sanofi, PCSK9 inhibitors
Glaxo-Theravance Lung Drug Gains Backing of FDA Advisers
Bloomberg
Wednesday, April 17, 2013 - 4:34pm
tags:
GSK, Breo Ellipta, FDA, COPD, Theravance
Top 10 pharma companies by employees
Fierce Pharma
Wednesday, April 17, 2013 - 11:31am
tags:
Novartis, JNJ, Sanofi, GSK, Pfizer, Abbott Laboratories, Merck, Roche, Bayer, AstraZeneca
Illumina: Thermo Fisher-Life Deal Unlikely To Threaten Its Market-Leading Position
Seeking Alpha
Wednesday, April 17, 2013 - 11:15am
tags:
Illumina, Thermo Fisher, M&A, Life Technologies, Pacific Biosciences
Mixed Messages on COPD Drug, FDA Review Finds
Med Page Today
Wednesday, April 17, 2013 - 11:13am
tags:
FDA, COPD, Breo Ellipta, GSK, Theravance
Did Someone Say Kickbacks? Amgen Pays $29M Over Aranesp Marketing
Pharmalot
Wednesday, April 17, 2013 - 11:08am
tags:
Amgen, Aranesp, kickbacks
3 Microcap Biopharma Plays For The H7N9 Influenza Outbreak
Seeking Alpha
Wednesday, April 17, 2013 - 11:07am
tags:
Flu, H7N9, Sanofi, Novavax, Biocryst, Gilead, GSK, Merck, Roche, Inovio

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.